#boehringer ingelheim

1 story

#fiscal 2026 #liquidity test #melanocortin receptor #palatin technologies #revenue inflection

Palatin's Revenue Jump Tests Liquidity
Palatin's fiscal 2026 revenue rise signals pipeline potential but liquidity remains tight.
Alphastreet - Earnings Decoded. Market Intelligence Delivered · 1m